Elevated CEA and CA199 levels in NSCLC patients are indicative of intrapulmonary and distant metastases; elevated CEA, CYFRA 21-1 and CA199 levels in patients with NSCLC are indicative of lymphatic metastasis. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.